Stock Price Quote

JAGSONPAL PHARMACEUTICALS LTD.

NSE : JAGSNPHARMBSE : 507789ISIN CODE : INE048B01027Industry : Pharmaceuticals & DrugsHouse : Jagsonpal
BSE156.652.7 (+1.75 %)
PREV CLOSE ( ) 153.95
OPEN PRICE ( ) 154.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1821
TODAY'S LOW / HIGH ( )154.15 157.15
52 WK LOW / HIGH ( )57.3 203.25
NSE156.152 (+1.3 %)
PREV CLOSE( ) 154.15
OPEN PRICE ( ) 155.20
BID PRICE (QTY) 156.15 (151)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 51543
TODAY'S LOW / HIGH( ) 153.40 157.20
52 WK LOW / HIGH ( )56.6 203.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1978
Management Info
R P S Kochhar - Chairman R P S Kochhar - Managing Director
Registered Office

Address T 210 J,Shabpur Jat, ,
New Delhi,
Delhi-110049

Phone 011-26494519-24

Email nandita.singh@jagsonpal.com

Website www.jagsonpal.com

Registrars Details
MCS Ltd
F-65, ,Okhla Industrial Area,Phase - I,New Delhi
 Listing : BSE, NSE, MCX

NEWS

20Oct Record Date For Interim Dividend
This is to inform that the Board of Directors has approved and declared..
20Oct Jagsonpal Pharmaceuticals informs abou
Jagsonpal Pharmaceuticals has informed that the Board of Directors has a..
19Oct Board declares Interim Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directo..
12Oct Board to consider Interim Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that Meeting of Board of..
12Oct Board Meeting Intimation for Quarterl
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the B..
MORE

Financials

in Millions
QTR Sep 21 ANNUAL 21
Net Profit73.08170.58
Gross Profit 102.75 218.72
Operating Profit 105.66234.72
Net Sales 594.891879.46
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  19088.00 (0.81%)
M.Cap ( in Cr)40560.67
Dr. Reddy's Lab (BSE)
peergroup  4655.55 (1.05%)
M.Cap ( in Cr)77468.32
Neuland Laboratories (BSE)
peergroup  1810.00 (2.74%)
M.Cap ( in Cr)2322.21
Caplin Point Lab (BSE)
peergroup  811.00 (6.30%)
M.Cap ( in Cr)6144.86
Ajanta Pharma (BSE)
peergroup  2125.00 (2.25%)
M.Cap ( in Cr)18388.85
MORE

Shareholding Pattern

PROMOTERS 70.34%
NON-INSTITUTION 29.54%
FII 0.11%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
MUTUAL FUNDS/UTI 0%
MORE

Mf Holdings

Scheme NameHold(%)
Taurus Flexi Cap Fu...0.11
MORE

About Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd. was incorporated in the year 1978. Its today's share price is 156.65. Its current market capitalisation stands at Rs 410.39 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1879.46 Cr and Total Income of Rs.1923.39 Cr. The company's management includes Ashok Kumar Pati, Nandita Singh, Mammen Mathew, Ishpal Singh Ghai, Bharat Sinh, Jasbir Kaur Kochhar, R P S Kochhar, R P S Kochhar.

It is listed on the BSE with a BSE Code of 507789 , NSE with an NSE Symbol of JAGSNPHARM and ISIN of INE048B01027. It's Registered office is at T 210 J,Shabpur Jat, New Delhi-110049, Delhi. Their Registrars are ACC Ltd. It's auditors are HL Bansal & Co, PP Thukral & Co

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX HolidaysMCX Data feed product and Charges
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy Inspection CSR Committee CSR Policy CSR Activities
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos